Minimal Detectable Changes of the Berg Balance Scale, Fugl-Meyer Assessment Scale, Timed “Up &amp; Go” Test, Gait Speeds, and 2-Minute Walk Test in Individuals With Chronic Stroke With Different Degrees of Ankle Plantarflexor Tone

Hiengkaew, Vimonwan; Jitaree, Khanitha; Chaiyawat, Pakaratee

doi:10.1016/j.apmr.2012.01.014

Cited by 266 publications

(185 citation statements)

References 45 publications

Supporting

Mentioning

162

Contrasting

Unclassified

Order By: Relevance

“…The intra‐rater and inter‐rater reliability for CMSA‐leg (ICC = 0.98 and 0.85), and CMSA‐foot (ICC = 0.94 and 0.96) was good (Gowland et al., 1993). For FMA‐LE, each item was scored on a 3‐point scale ranging from 0 to 2 (maximum score of 34) (Hiengkaew, Jitaree, & Chaiyawat, 2012). The FMA‐LE had good intra‐rater and inter‐rater reliability (0.95 and 0.92 respectively) among individuals with chronic stroke (Hiengkaew et al., 2012).…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Psychometric properties of Brief‐Balance Evaluation Systems Test (Brief‐BESTest) in evaluating balance performance in individuals with chronic stroke

Huang

Pang

2017

Brain and Behavior

View full text Add to dashboard Cite

ObjectiveTo examine the psychometric properties of the Brief‐Balance Evaluation Systems Test (Brief‐BESTest) in individuals with chronic stroke.Materials and MethodsThis was an observational study with repeated measurements involving 50 participants with chronic stroke [mean (SD) age: 59.2 (7.3) years]. Each participant with stroke was evaluated with the Brief‐BESTest, Berg balance scale (BBS), Postural Assessment Scale for Stroke Patients (PASS), Fugl‐Meyer Motor Assessment (FMA), Chedoke‐McMaster Stroke Assessment (CMSA), Montreal Cognitive Assessment (MoCA), and Geriatric Depression Scale (GDS). Two raters (rater 1 and 2) provided the Brief‐BESTest scores of the first 27 participants independently to establish inter‐rater reliability. After 15 min of rest, the same 27 participants were evaluated with the Brief‐BESTest again by rater 1 to establish intra‐rater reliability. The Brief‐BESTest scores of the stroke group were also compared with those of the control group [n = 27, mean (SD) age: 56.7 (7.7) years].ResultsThe Brief‐BESTest had no substantial floor and ceiling effects, good intra‐rater (ICC 2,1 = 0.974) and inter‐rater (ICC 2,1 = 0.980) reliability and internal consistency (Cronbach's alpha = 0.818). The minimal detectable change at 95% confidence level was 2 points. The Brief‐BESTest showed moderate to very strong correlations with other balance (BBS and PASS) and motor impairment (FMA, CMSA) measures (r s = .547–.911, p < .001), thus revealing good concurrent and convergent validity. Its correlation with measures that evaluated other constructs was weaker (MoCA: r s = .437, p = .002) or non‐significant (GDS: r s = −0.152, p = .292), thus showing good discriminant validity. Good known‐groups validity was established, as the Brief‐BESTest was effective in distinguishing participants with stroke from controls (cutoff score: <18, area under curve: 0.942), and individuals with stroke who required assistive device for their outdoor mobility from those who did not (cutoff score <14, area under curve: 0.810).ConclusionsThe Brief‐BESTest has good reliability and validity in assessing balance function in individuals with chronic stroke.

show abstract

Section: Methodsmentioning

confidence: 99%

“…For FMA‐LE, each item was scored on a 3‐point scale ranging from 0 to 2 (maximum score of 34) (Hiengkaew, Jitaree, & Chaiyawat, 2012). The FMA‐LE had good intra‐rater and inter‐rater reliability (0.95 and 0.92 respectively) among individuals with chronic stroke (Hiengkaew et al., 2012). …”

Section: Methodsmentioning

confidence: 99%

Psychometric properties of Brief‐Balance Evaluation Systems Test (Brief‐BESTest) in evaluating balance performance in individuals with chronic stroke

Huang

Pang

2017

Brain and Behavior

View full text Add to dashboard Cite

show abstract

“…The maximum score is 56, and a higher score indicates better balance performance. The BBS has shown excellent test–retest reliability (ICC, 0.95)40 in the assessment of subjects with stroke. To dampen the ceiling effect, a standardized assessment procedure was implemented to challenge the paretic leg's weight‐bearing ability 41…”

Section: Methodsmentioning

confidence: 99%

Bilateral Transcutaneous Electrical Nerve Stimulation Improves Lower‐Limb Motor Function in Subjects With Chronic Stroke: A Randomized Controlled Trial

Kwong

Chung

et al. 2018

JAHA

View full text Add to dashboard Cite

BackgroundTranscutaneous electrical nerve stimulation (TENS) has been used to augment the efficacy of task‐oriented training (TOT) after stroke. Bilateral intervention approaches have also been shown to be effective in augmenting motor function after stroke. The purpose of this study was to compare the efficacy of bilateral TENS combined with TOT versus unilateral TENS combined with TOT in improving lower‐limb motor function in subjects with chronic stroke.Methods and ResultsEighty subjects were randomly assigned to bilateral TENS+TOT or to unilateral TENS+TOT and underwent 20 sessions of training over a 10‐week period. The outcome measures included the maximal strength of the lower‐limb muscles and the results of the Lower Extremity Motor Coordination Test, Berg Balance Scale, Step Test, and Timed Up and Go test. Each participant was assessed at baseline, after 10 and 20 sessions of training and 3 months after the cessation of training. The subjects in the bilateral TENS+TOT group showed greater improvement in paretic ankle dorsiflexion strength (β=1.32; P=0.032) and in the completion time for the Timed Up and Go test (β=−1.54; P=0.004) than those in the unilateral TENS+TOT group. However, there were no significant between‐group differences for other outcome measures.ConclusionsThe application of bilateral TENS over the common peroneal nerve combined with TOT was superior to the application of unilateral TENS combined with TOT in improving paretic ankle dorsiflexion strength after 10 sessions of training and in improving the completion time for the Timed Up and Go test after 20 sessions of training.Clinical Trial Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT02152813.

show abstract

“…However, the impact of cancer treatment on a chronic stroke survivor's neurorehabilitation response has not been explored. Therefore, this case study provides the treatment response to a longdose, 10-month neurorehabilitation program for a chronic stroke Her lower limb coordination improved 6 points (Fugl-Meyer MDC = 3.57 [7]. Function.…”

Section: Introductionmentioning

confidence: 99%

“…The Functional Gait Assessment improved 6 points (minimum detectable change (MCD) = 4.2, Lin et al 2010). The mobility test, the TUG, improved 9.82sec (MDC = 3.16sec; [7]). Aerobic capacity/fitness endurance progressed from initial capability of only 3 min continuous cycling to ability to cycling for 45 min at a moderate intensity level, 2x/week.…”

Section: Introductionmentioning

confidence: 99%

Feasibility and benefit of long-dose stroke neurorehabilitation which produced and maintained balance and mobility gains throughout cancer surgery and radiation treatment

Boissoneault¹,

Khanna²,

Daly³

2018

Vascul Dis Ther

View full text Add to dashboard Cite

Purpose: This case study provides quantitative evidence of the feasibility and benefit of a long-dose, 10-month neurorehabilitation program for a chronic stroke survivor who, in the midst of the neurorehabilitation program, underwent surgery and radiation treatment for breast cancer. Methods:The patient was age 60 years, and 6 years post-stroke (left middle cerebral artery stroke), exhibiting impairments in balance, strength, and gait coordination, as well as deficits in functional mobility, and compromised quality of life. Her comprehensive mobility/fitness neurorehabilitation program included aerobics, strength and coordination training, and balance and gait coordination training. Treatment was 1.5 -2 hours per day, 5 days/week for 6 months, followed by an additional 4 months of treatment 3 days/week. Outcome measures were acquired at entry into the neurorehabilitation program, and at months 2, 4, 6, 8 and 10. Measures included the following: modified Ashworth (mASH, spasticity); Fugl-Meyer (FM; isolated limb joint coordination); 6-minute walk test (6MWT; walking endurance); gait speed; Berg Balance Scale (BBS; static and dynamic balance); Timed Up and Go (TUG; mobility); 10 Meter Walk Test (10MWT; short distance, self-selected and fast walking speed); Functional Gait Assessment (FGA; dynamic balance and postural stability during gait); Functional Independence Measure (FIM; assessment of functional status and disability); Craig Handicap Assessment and Reporting Technique (CHART; quality of life assessment of how patients with disabilities function in the community and at home); 36-Item Short Form Survey (SF36; quality of life measure); and the Stroke Impact Scale (SIS; stroke-specific quality of life measure). Fatigue level was queried during and following radiation therapy.Results: From baseline through month 4, the patient demonstrated improvements in most outcome measures. For example, she improved from 3 minutes of cycling endurance to 45 minutes, and balance improvement reached the threshold for functional independence. At month 5, she was diagnosed with breast cancer and underwent a partial mastectomy. She underwent radiation treatment, which concluded in month 7. Prior, during, and after the cancer treatment, she continued participation in the neurorehabilitation program.Following the partial mastectomy, she exhibited continued improvement in BBS, 10MWT-normal speed, FGA, CHART, SF-36, and SIS. Notably, the TUG continued to improve significantly by 4.73sec. She showed some decline in values for the 6MWT, gait speed, and 10MWT-fast walking speed.Four weeks following the end of the course of radiation therapy, most measures showed a small decline. But in contrast, by 12 weeks after the end of radiation (which coincided with 10 months of participation in the neurorehabilitation program), the following measures showed a revival in improvement: Fugl-Myer (limb coordination); 6MWT (walking endurance); gait speed; BBS (balance); FIM (functional tasks); subdomains of the CHART quality of life measure (p...

show abstract

Minimal Detectable Changes of the Berg Balance Scale, Fugl-Meyer Assessment Scale, Timed “Up & Go” Test, Gait Speeds, and 2-Minute Walk Test in Individuals With Chronic Stroke With Different Degrees of Ankle Plantarflexor Tone

Cited by 266 publications

References 45 publications

Psychometric properties of Brief‐Balance Evaluation Systems Test (Brief‐BESTest) in evaluating balance performance in individuals with chronic stroke

Psychometric properties of Brief‐Balance Evaluation Systems Test (Brief‐BESTest) in evaluating balance performance in individuals with chronic stroke

Bilateral Transcutaneous Electrical Nerve Stimulation Improves Lower‐Limb Motor Function in Subjects With Chronic Stroke: A Randomized Controlled Trial

Feasibility and benefit of long-dose stroke neurorehabilitation which produced and maintained balance and mobility gains throughout cancer surgery and radiation treatment

Contact Info

Product

Resources

About